A crucial assist in April 2020 from Lab scientist Jay Nix of the ALS’s Molecular Biology Consortium helped lead to the discovery of sotrovimab, which neutralizes all known SARS-CoV-2 strains, including mutants. The Mercury News tells how this led to developing a vital COVID antibody therapy. https://www.mercurynews.com/2022/01/23/covid-how-one-persons-cells-led-to-our-only-antibody-treatment-for-omicron/
January 2019 – July 2022
